{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T10:55:32Z","timestamp":1788346532297,"version":"build-2803163510"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      We aimed to compare the sperm quality in different cancer types and benign diseases before gonadotoxic treatment, and assess the usage rate of cryopreserved sperm for assisted reproductive treatment (ART). This retrospective study was conducted at two university clinics between January 2008 and July 2018. A total of 545 patients suffering from cancer or benign diseases were included in the study. The pretreatment sperm analyses were based on the World Health Organization (WHO) guidelines. Patients with testicular malignancy (TM) showed a significantly lower sperm count (median [interquartile range]: 18.7 \u00d7 10\n                      <jats:sup>6<\/jats:sup>\n                      [5.3 \u00d7 10\n                      <jats:sup>6<\/jats:sup>\n                      \u201343.0 \u00d7 10\n                      <jats:sup>6<\/jats:sup>\n                      ] ml\n                      <jats:sup>\u22121<\/jats:sup>\n                      ;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.03) as well as total sperm count (42.4 \u00d7 10\n                      <jats:sup>6<\/jats:sup>\n                      [13.3 \u00d7 10\n                      <jats:sup>6<\/jats:sup>\n                      \u2013108.5 \u00d7 10\n                      <jats:sup>6<\/jats:sup>\n                      ] per ejaculate;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.007) compared to other malignant and benign diseases. In addition, patients with nonseminomatous TM showed the lowest sperm count (14.3 \u00d7 10\n                      <jats:sup>6<\/jats:sup>\n                      [6.0 \u00d7 10\n                      <jats:sup>6<\/jats:sup>\n                      \u201329.9 \u00d7 10\n                      <jats:sup>6<\/jats:sup>\n                      ] ml\n                      <jats:sup>\u22121<\/jats:sup>\n                      ,\n                      <jats:italic toggle=\"yes\">vs<\/jats:italic>\n                      seminomas: 16.5 \u00d7 10\n                      <jats:sup>6<\/jats:sup>\n                      [4.6 \u00d7 10\n                      <jats:sup>6<\/jats:sup>\n                      \u201320.3 \u00d7 10\n                      <jats:sup>6<\/jats:sup>\n                      ] ml\n                      <jats:sup>\u22121<\/jats:sup>\n                      ;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.001). With reference to the WHO 2010 guidelines, approximately 48.0% of the patients with TM and 23.0% with hematological malignancies (HM) had oligozoospermia. During the observation period, only 29 patients (5.3%) used their frozen sperms for 48 ART cycles, resulting in 15 clinical pregnancies and 10 live births. The sperm quality varies with the type of underlying disease, with TM and HM patients showing the lowest sperm counts. Due to the observed low usage rate of cryopreserved sperm, further patient interviews and sperm analyses should be included in the routine oncologic protocols to avoid unnecessary storage expenses. However, sperm banking is worth the effort as it provides hope for men who cannot reproduce naturally after gonadotoxic treatment.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/aja.aja_16_21","type":"journal-article","created":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T06:17:37Z","timestamp":1616739457000},"page":"490-494","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":18,"title":["Sperm banking before gonadotoxic treatment"],"prefix":"10.4103","volume":"23","author":[{"given":"Kilian","family":"Vomstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Reiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Germar M","family":"Pinggera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Toerzsoek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Deininger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kriesche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Biasio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Lusuardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Toth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20240829","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s11864-012-0191-7","article-title":"Oncofertility and the male cancer patient","volume":"13","author":"Trost","year":"2012","journal-title":"Curr Treat Options Oncol"},{"key":"R2-9-20240829","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.rbmo.2015.11.005","article-title":"Semen cryopreservation and usage rate for assisted reproductive technology in 898 men with cancer","volume":"32","author":"Muller","year":"2016","journal-title":"Reprod Biomed Online"},{"key":"R3-9-20240829","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/(SICI)1097-0142(19990815)86:4<697::AID-CNCR20>3.0.CO;2-J","article-title":"Having children after cancer. A pilot survey of survivors\u2019 attitudes and experiences","volume":"86","author":"Schover","year":"1999","journal-title":"Cancer"},{"key":"R4-9-20240829","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.eururo.2005.05.002","article-title":"Twenty years experience with semen cryopreservation in testicular cancer patients: who needs it?","volume":"48","author":"Magelssen","year":"2005","journal-title":"Eur Urol"},{"key":"R5-9-20240829","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0015-0282(03)00335-2","article-title":"Fertility in men with testicular germ cell tumors","volume":"79","author":"Spermon","year":"2003","journal-title":"Fertil Steril"},{"key":"R6-9-20240829","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0140-6736(75)90059-8","article-title":"Return of spermatogenesis after stopping cyclophosphamide therapy","volume":"2","author":"Buchanan","year":"1975","journal-title":"Lancet"},{"key":"R7-9-20240829","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1046\/j.1365-2265.2002.t01-1-01545.x","article-title":"Testicular dose and fertility in men following I[131] therapy for thyroid cancer","volume":"56","author":"Hyer","year":"2002","journal-title":"Clin Endocrinol (Oxf"},{"key":"R8-9-20240829","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.ejca.2008.11.042","article-title":"Survival of European children and young adults with cancer diagnosed 1995-2002","volume":"45","author":"Gatta","year":"2009","journal-title":"Eur J Cancer"},{"key":"R9-9-20240829","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S1470-2045(17)30677-0","article-title":"Cancer incidence and mortality among young adults aged 20-39 years worldwide in 2012: a population-based study","volume":"18","author":"Fidler","year":"2017","journal-title":"Lancet Oncol"},{"key":"R10-9-20240829","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1440-1673.1978.tb02091.x","article-title":"Sperm bank potentials in the management of malignancy","volume":"22","author":"Saunders","year":"1978","journal-title":"Australas Radiol"},{"key":"R11-9-20240829","first-page":"2853","article-title":"Spermatogenesis in tumor-bearing testes in germ cell testicular cancer patients","volume":"30","author":"Suzuki","year":"2015","journal-title":"Hum Reprod"},{"key":"R12-9-20240829","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/jnci\/82.5.412","article-title":"Mechanisms of endocrine dysfunction in patients with testicular cancer","volume":"82","author":"Morrish","year":"1990","journal-title":"J Natl Cancer Inst"},{"key":"R13-9-20240829","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2605.2009.00956.x","article-title":"Gonadal dysfunction in male cancer patients before cytotoxic treatment","volume":"33","author":"van Casteren","year":"2010","journal-title":"Int J Androl"},{"key":"R14-9-20240829","first-page":"263","article-title":"Spermatogenesis in Hodgkin's lymphoma patients: a retrospective study of semen quality before and after different chemotherapy regimens","volume":"31","author":"Paoli","year":"2016","journal-title":"Hum Reprod"},{"key":"R15-9-20240829","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.3324\/haematol.2009.009696","article-title":"Sperm quality before treatment in patients with early stage Hodgkin's lymphoma enrolled in EORTC-GELA Lymphoma Group trials","volume":"94","author":"van der Kaaij","year":"2009","journal-title":"Haematologica"},{"key":"R17-9-20240829","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1055\/a-0611-5549","article-title":"Fertility Preservation for Patients with Malignant Disease. Guideline of the DGGG, DGU and DGRM (S2k-Level, AWMF Registry No. 015\/082, November 2017) - Recommendations and Statements for Girls and Women","volume":"78","author":"Dittrich","year":"2018","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"R18-9-20240829","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s10815-013-9998-9","article-title":"Live births from frozen human semen stored for 40 years","volume":"30","author":"Szell","year":"2013","journal-title":"J Assist Reprod Genet"},{"key":"R19-9-20240829","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/aja.2013.3","article-title":"Preservation of sperm of cancer patients: extent of use and pregnancy outcome in a tertiary infertility center","volume":"15","author":"Botchan","year":"2013","journal-title":"Asian J Androl"},{"key":"R20-9-20240829","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.rbmo.2011.11.015","article-title":"Sperm cryopreservation before cancer treatment: a 15-year monocentric experience","volume":"24","author":"Bizet","year":"2012","journal-title":"Reprod Biomed Online"},{"key":"R21-9-20240829","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.fertnstert.2005.08.022","article-title":"Sperm cryopreservation in oncological patients: a 14-year follow-up study","volume":"85","author":"Meseguer","year":"2006","journal-title":"Fertil Steril"},{"key":"R23-9-20240829","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1439-0272.2005.00700.x","article-title":"Testicular dysgenesis and fertility","volume":"37","author":"Skakkebaek","year":"2005","journal-title":"Andrologia"},{"key":"R24-9-20240829","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.2164\/jandrol.112.016592","article-title":"The semen quality of 1158 men with testicular cancer at the time of cryopreservation: results of the French National CECOS Network","volume":"33","author":"Rives","year":"2012","journal-title":"J Androl"},{"key":"R25-9-20240829","doi-asserted-by":"crossref","first-page":"166","DOI":"10.5534\/wjmh.180043","article-title":"Recovery of spermatogenesis following cancer treatment with cytotoxic chemotherapy and radiotherapy","volume":"37","author":"Okada","year":"2019","journal-title":"World J Mens Health"},{"key":"R26-9-20240829","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1442-2042.2010.02484.x","article-title":"Male infertility in cancer patients: review of the literature","volume":"17","author":"Dohle","year":"2010","journal-title":"Int J Urol"},{"key":"R27-9-20240829","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.urology.2012.10.038","article-title":"Predictors of spermatogenesis in orchiectomy specimens","volume":"81","author":"Choy","year":"2013","journal-title":"Urology"},{"key":"R28-9-20240829","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1200\/JCO.2006.06.5888","article-title":"American Society of Clinical Oncology recommendations on fertility preservation in cancer patients","volume":"24","author":"Lee","year":"2006","journal-title":"J Clin Oncol"},{"key":"R30-9-20240829","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1016\/j.fertnstert.2007.10.055","article-title":"Use rate and assisted reproduction technologies outcome of cryopreserved semen from 629 cancer patients","volume":"90","author":"van Casteren","year":"2008","journal-title":"Fertil Steril"},{"key":"R31-9-20240829","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1093\/humrep\/deh518","article-title":"Assisted reproduction in male cancer survivors: fertility treatment and outcome in 67 couples","volume":"19","author":"Schmidt","year":"2004","journal-title":"Hum Reprod"},{"key":"R32-9-20240829","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.fertnstert.2005.01.121","article-title":"In vitro fertilization-intracytoplasmic sperm injection success rates with cryopreserved sperm from patients with malignant disease","volume":"84","author":"Revel","year":"2005","journal-title":"Fertil Steril"},{"key":"R33-9-20240829","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1046\/j.1365-2605.2001.00260.x","article-title":"Infancy is not a quiescent period of testicular development","volume":"24","author":"Chemes","year":"2001","journal-title":"Int J Androl"},{"key":"R34-9-20240829","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/pbc.22004","article-title":"Male gonadal toxicity","volume":"53","author":"Meistrich","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"R35-9-20240829","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1093\/annonc\/mdq579","article-title":"Who should be offered sperm banking for fertility preservation? A survey of UK oncologists and haematologists","volume":"22","author":"Gilbert","year":"2011","journal-title":"Ann Oncol"},{"key":"R36-9-20240829","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.fertnstert.2007.08.064","article-title":"Infertility induced by cancer treatment: inappropriate or no information provided to majority of French survivors of cancer","volume":"90","author":"Mancini","year":"2008","journal-title":"Fertil Steril"},{"key":"R37-9-20240829","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.eururo.2007.03.085","article-title":"Semen quality in men with malignant diseases before and after therapy and the role of cryopreservation","volume":"52","author":"Trottmann","year":"2007","journal-title":"Eur Urol"},{"key":"R38-9-20240829","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1200\/JCO.2002.07.174","article-title":"Oncologists\u2019 attitudes and practices regarding banking sperm before cancer treatment","volume":"20","author":"Schover","year":"2002","journal-title":"J Clin Oncol"},{"key":"R39-9-20240829","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/cncr.21185","article-title":"Sperm cryopreservation before cancer chemotherapy helps in the emotional battle against cancer","volume":"104","author":"Saito","year":"2005","journal-title":"Cancer"},{"key":"R40-9-20240829","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1093\/humrep\/der243","article-title":"The legacy of sperm banking: how fertility monitoring and disposal of sperm are linked with views of cancer treatment","volume":"26","author":"Eiser","year":"2011","journal-title":"Hum Reprod"}],"container-title":["Asian Journal of Andrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/aja.aja_16_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:23:24Z","timestamp":1787844204000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/aja.aja_16_21"}},"subtitle":["is it worth the effort?"],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/aja.aja_16_21","relation":{},"ISSN":["1008-682X"],"issn-type":[{"value":"1008-682X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]}}}